ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2022 (Información remitida por la empresa firmante) Zinzino group revenue increased with a total of 6% in Q4 and 5% for the full year 2022, compared with the previous year GOTHENBURG, Sweden, Jan.
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
Two university hospitals in France digitize pathology with Sectra to enable efficient sharing of resources and expertise
Bioretec has submitted additional information requested by the FDA for US registration of RemeOs Trauma Screws, and the
La FDA concede la designación de gran avance a un análisis de sangre para diagnosticar tumores cerebrales
Baraja recibe inversión de Veoneer tras el acuerdo de desarrollo avanzado con un OEM global de automoción
